Breaking News
Investing Pro 0
Black Friday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER

CVS quarterly profit beats; expects to close Aetna deal this month

Stock Markets Nov 06, 2018 10:43AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Shoppers walk outside a CVS store and pharmacy in Medford
 
AET
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CVS
+1.20%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Manas Mishra

(Reuters) - CVS Health Corp (N:CVS), which expects to close its $69 billion purchase of Aetna Inc (N:AET) this month, reported third-quarter profit that beat analysts' estimates on higher sales of prescription drugs.

Shares of the drugstore chain and pharmacy benefit manager (PBM) were up 2.7 percent at $75.70 in morning trading.

The company said it believes the Aetna deal will help it save more than $750 million in costs in the second year after it closes, as the combination reduces corporate expenses as well as produces "some" cuts in medical costs from decreased emergency room visits.

"The longer term medical cost savings will come from new programs that are only made possible through the combination and close integration of our two companies," Chief Executive Officer Larry Menlo said on call with analysts.

CVS, which last month won U.S. Department of Justice approval to buy Aetna, said it reached agreement with the state of California on the acquisition and expects to finalize terms over the coming days. The deal is expected to close before the Thanksgiving holiday, which falls on Nov. 22, CVS said.

The combination is expected to reshape the healthcare sector as it brings together one of the largest PBMs and one of the nation's oldest health insurers.

CVS could offer more preventive care services and screenings to Aetna customers in its clinics, such as enabling diabetes patients to monitor blood sugar levels, avoiding higher cost visits to doctors or emergency rooms.

Pharmacy same-store sales rose 8.7 percent in the quarter, while analysts were expecting a 7.7 percent rise.

Front end of the store same-store sales rose 0.8 percent versus analysts' expectations of an 0.8 percent drop, despite brick-and-mortar drugstore chains like CVS coming under increasing pressure from consumer shifts to online options.

Sales of beauty products at CVS stores have benefited from promotions and newer offerings. Last year, the company announced a initiative to offer over a hundred new South Korean beauty brands at its stores.

Excluding items, CVS Health said it earned $1.73 per share, topping analysts' average estimates by 2 cents.

Net revenue rose 2.4 percent to $47.27 billion, beating expectation of $47.18 billion.

Net income rose to $1.39 billion, or $1.36 per share, in the quarter. Its income tax provision declined by $268 million. (https://

CVS quarterly profit beats; expects to close Aetna deal this month
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email